2021 annual financial data
Ensysce Biosciences 2021 Operating cash flow
Direct answer
Operating cash flow was -8,242,177 USD.
Operating income was -19,870,431 USD and net income was -29,145,750 USD.
Operating cash flow was -8,242,177 USD.
Get free Ensysce Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,531,200 USD
- Operating income
- -19,870,431 USD
- Net income
- -29,145,750 USD
- Operating cash flow
- -8,242,177 USD